Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-17-001547
Filing Date
2017-02-14
Accepted
2017-02-14 17:33:33
Documents
69
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 10-K mnov-10k_20161231.htm 10-K 2566102
2 EX-23.1 mnov-ex231_10.htm EX-23.1 2802
3 EX-23.2 mnov-ex232_9.htm EX-23.2 4728
4 EX-31.1 mnov-ex311_6.htm EX-31.1 8473
5 EX-31.2 mnov-ex312_11.htm EX-31.2 8411
6 EX-32.1 mnov-ex321_7.htm EX-32.1 6734
7 EX-32.2 mnov-ex322_8.htm EX-32.2 7021
8 GRAPHIC g2017021419231523315877.jpg GRAPHIC 27188
  Complete submission text file 0001564590-17-001547.txt   7366913

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT mnov-20161231.xml EX-101.INS 1460109
10 XBRL TAXONOMY EXTENSION SCHEMA mnov-20161231.xsd EX-101.SCH 42359
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mnov-20161231_cal.xml EX-101.CAL 44719
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mnov-20161231_def.xml EX-101.DEF 132564
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnov-20161231_lab.xml EX-101.LAB 357661
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnov-20161231_pre.xml EX-101.PRE 277596
Mailing Address 4275 EXECUTIVE SQUARE SUITE 650 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE SUITE 650 LA JOLLA CA 92037 858-373-1500
MEDICINOVA INC (Filer) CIK: 0001226616 (see all company filings)

EIN.: 330927979 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33185 | Film No.: 17610822
SIC: 2834 Pharmaceutical Preparations